151 related articles for article (PubMed ID: 17921793)
21. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.
Calvo-Alén J; McGwin G; Toloza S; Fernández M; Roseman JM; Bastian HM; Cepeda EJ; González EB; Baethge BA; Fessler BJ; Vilá LM; Reveille JD; Alarcón GS;
Ann Rheum Dis; 2006 Jun; 65(6):785-90. PubMed ID: 16269429
[TBL] [Abstract][Full Text] [Related]
22. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
23. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria.
Bastian HM; Alarcón GS; Roseman JM; McGwin G; Vilá LM; Fessler BJ; Reveille JD;
Rheumatology (Oxford); 2007 Apr; 46(4):683-9. PubMed ID: 17132694
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort.
Durán-Barragán S; McGwin G; Vilá LM; Reveille JD; Alarcón GS;
Rheumatology (Oxford); 2008 Jul; 47(7):1093-6. PubMed ID: 18511474
[TBL] [Abstract][Full Text] [Related]
25. [Hormone replacement therapy and venous thromboembolism].
Trillot N; Susen S; Jude B
Gynecol Obstet Fertil; 2004 Sep; 32(9):725-8. PubMed ID: 15380753
[TBL] [Abstract][Full Text] [Related]
26. Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort.
Pons-Estel GJ; González LA; Zhang J; Burgos PI; Reveille JD; Vilá LM; Alarcón GS
Rheumatology (Oxford); 2009 Jul; 48(7):817-22. PubMed ID: 19454606
[TBL] [Abstract][Full Text] [Related]
27. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups.
Mok CC; Tang SS; To CH; Petri M
Arthritis Rheum; 2005 Sep; 52(9):2774-82. PubMed ID: 16142761
[TBL] [Abstract][Full Text] [Related]
28. Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII).
González LA; Pons-Estel GJ; Zhang JS; McGwin G; Roseman J; Reveille JD; Vilá LM; Alarcón GS;
Lupus; 2009 Feb; 18(2):184-6. PubMed ID: 19151125
[No Abstract] [Full Text] [Related]
29. African-American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV).
Chaiamnuay S; Bertoli AM; Roseman JM; McGwin G; Apte M; Durán S; Vilá LM; Reveille JD; Alarcón GS
Ann Rheum Dis; 2007 May; 66(5):618-22. PubMed ID: 17107981
[TBL] [Abstract][Full Text] [Related]
30. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.
Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
J Rheumatol; 2005 Nov; 32(11):2150-5. PubMed ID: 16265693
[TBL] [Abstract][Full Text] [Related]
31. Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected].
Andrade R; Sanchez ML; Alarcón GS; Fessler BJ; Fernández M; Bertoli AM; Apte M; Vilá LM; Arango AM; Reveille JD;
Clin Exp Rheumatol; 2008; 26(2):268-74. PubMed ID: 18565248
[TBL] [Abstract][Full Text] [Related]
32. Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXXI: factors associated with patients being lost to follow-up.
Bertoli AM; Fernández M; Calvo-Alén J; Vilá LM; Sanchez ML; Reveille JD; Alarcón GS;
Lupus; 2006; 15(1):19-25. PubMed ID: 16482741
[TBL] [Abstract][Full Text] [Related]
33. Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII).
Andrade RM; McGwin G; Alarcón GS; Sanchez ML; Bertoli AM; Fernández M; Fessler BJ; Apte M; Arango AM; Bastian HM; Vilá LM; Reveille JD;
Rheumatology (Oxford); 2006 Nov; 45(11):1380-4. PubMed ID: 16880189
[TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy in systemic lupus erythematosus.
Kreidstein S; Urowitz MB; Gladman DD; Gough J
J Rheumatol; 1997 Nov; 24(11):2149-52. PubMed ID: 9375875
[TBL] [Abstract][Full Text] [Related]
35. Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study.
Douketis JD; Julian JA; Kearon C; Anderson DR; Crowther MA; Bates SM; Barone M; Piovella F; Turpie AG; Middeldorp S; van Nguyen P; Prandoni P; Wells PS; Kovacs MJ; MacGillavry MR; Costantini L; Ginsberg JS
J Thromb Haemost; 2005 May; 3(5):943-8. PubMed ID: 15869589
[TBL] [Abstract][Full Text] [Related]
36. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII).
Tucker LB; Uribe AG; Fernández M; Vilá LM; McGwin G; Apte M; Fessler BJ; Bastian HM; Reveille JD; Alarcón GS
Lupus; 2008 Apr; 17(4):314-22. PubMed ID: 18413413
[TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group.
Alarcón GS; McGwin G; Bastian HM; Roseman J; Lisse J; Fessler BJ; Friedman AW; Reveille JD
Arthritis Rheum; 2001 Apr; 45(2):191-202. PubMed ID: 11324784
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
[TBL] [Abstract][Full Text] [Related]
39. Systemic lupus erythematosus in a multi-ethnic cohort (LUMINA) XXXII: [corrected] contributions of admixture and socioeconomic status to renal involvement.
Alarcón GS; Bastian HM; Beasley TM; Roseman JM; Tan FK; Fessler BJ; Vilá LM; McGwin G;
Lupus; 2006; 15(1):26-31. PubMed ID: 16482742
[TBL] [Abstract][Full Text] [Related]
40. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
